The initiative is being implemented at the University of Rochester’s Center for Human Experimental Therapeutics after the university received a $1-million contract to launch the program.
Join the ACTION
The initiative has issued a Request for Information (RFI) to facilitate its proposed research projects. The RFI asks for any information, suggestions, and recommendations, offering all subspecialties the opportunity to join the initiative and provide research designs to help finalize ACTION’s strategic plan.
Responses to the RFI will be accepted through May 1, 2011 and may be submitted by e-mail to [email protected].
Dr. Clauw hopes that the rheumatologists respond to, and are well represented in, the initiative. “The ACR’s representation on ACTION will ensure that rheumatologists know of their initiatives as they are developed, and can take advantage of them,” he says.
Kevin Stevens is a writer based in New Jersey.
